Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-055675
Filing Date
2020-05-01
Accepted
2020-05-01 17:28:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2017919-2_424b5.htm 424B5 716979
2 GRAPHIC lg_fennecpharma-4clr.jpg GRAPHIC 123944
  Complete submission text file 0001104659-20-055675.txt   889112
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221093 | Film No.: 20841988
SIC: 2836 Biological Products, (No Diagnostic Substances)